Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,394 | 71 | 50.0% |
| Travel and Lodging | $1,293 | 2 | 46.4% |
| Education | $99.99 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $1,717 | 11 | $0 (2021) |
| ABBVIE INC. | $366.42 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $220.52 | 8 | $0 (2022) |
| Allergan, Inc. | $128.94 | 9 | $0 (2021) |
| Eisai Inc. | $77.20 | 5 | $0 (2021) |
| Currax Pharmaceuticals LLC | $66.52 | 4 | $0 (2022) |
| TherapeuticsMD, Inc. | $54.88 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.72 | 2 | $0 (2022) |
| UROVANT SCIENCES INC | $33.22 | 2 | $0 (2022) |
| Bausch Health US, LLC | $22.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.71 | 1 | ABBVIE INC. ($17.71) |
| 2022 | $221.89 | 13 | ABBVIE INC. ($45.83) |
| 2021 | $2,547 | 60 | Axonics, Inc. ($1,717) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/19/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: WOMENS HEALTH | ||||||
| 06/28/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/26/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Neurology | ||||||
| 04/04/2022 | Hollister Incorporated | Infyna Chic (Device) | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| Category: Continence Care | ||||||
| 04/01/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Urology | ||||||
| 04/01/2022 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Analgesic| antispasmodic & antiseptic (urinary) | ||||||
| 03/24/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: Urology | ||||||
| 03/03/2022 | PFIZER INC. | PREMARIN (Drug), PREMARIN, MYFEMBREE | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: WOMENS HEALTH | ||||||
| 02/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug), IMVEXXY | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 01/13/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Obesity | ||||||
| 12/16/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: OBESITY | ||||||
| 12/09/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: WOMENS HEALTH | ||||||
| 11/30/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Neurology | ||||||
| 11/09/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: OBESITY | ||||||
| 11/08/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Urology | ||||||
| 11/04/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: WOMENS HEALTH | ||||||
| 10/26/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: WOMENS HEALTH | ||||||
| 10/26/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/20/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: WOMENS HEALTH | ||||||
| 10/13/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Neurology | ||||||
| 10/04/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 14 | 959 | 1,174 | $144,377 | $50,597 |
| 2020 | 15 | 1,057 | 1,288 | $143,679 | $37,794 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 134 | 155 | $27,745 | $15,039 | 54.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 203 | $26,999 | $13,045 | 48.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 87 | 87 | $22,272 | $9,838 | 44.2% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 30 | 99 | $19,800 | $4,599 | 23.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 315 | 368 | $16,192 | $2,038 | 12.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $3,200 | $1,411 | 44.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 40 | 47 | $2,538 | $1,238 | 48.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 22 | 22 | $1,144 | $666.16 | 58.2% |
| 17250 | Application of chemical agent to excessive wound tissue | Office | 2021 | 16 | 16 | $3,600 | $623.26 | 17.3% |
| 95972 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with complex spinal cord or peripheral nerve stimulator programming | Office | 2021 | 18 | 19 | $5,757 | $605.20 | 10.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 22 | $1,980 | $547.68 | 27.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 61 | 62 | $7,150 | $410.73 | 5.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 25 | 28 | $840.00 | $290.22 | 34.6% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Office | 2021 | 29 | 30 | $5,160 | $246.80 | 4.8% |
| 51729 | Insertion of electronic device into bladder with voiding and bladder canal (urethra) pressure studies | Office | 2020 | 41 | 41 | $20,500 | $6,988 | 34.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 133 | 166 | $14,980 | $6,658 | 44.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 169 | 239 | $12,906 | $5,688 | 44.1% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2020 | 51 | 51 | $12,240 | $4,300 | 35.1% |
| 51700 | Bladder irrigation and/or instillation | Office | 2020 | 37 | 94 | $18,800 | $4,131 | 22.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 47 | 47 | $6,110 | $2,461 | 40.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 53 | 53 | $4,770 | $1,983 | 41.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 291 | 337 | $14,828 | $1,939 | 13.1% |
| A4562 | Pessary, non rubber, any type | Office | 2020 | 26 | 28 | $2,100 | $1,106 | 52.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 84 | 98 | $9,100 | $485.90 | 5.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2020 | 48 | 48 | $14,400 | $479.72 | 3.3% |
About Amanda Hill, DNP, NP-C
Amanda Hill, DNP, NP-C is a Primary Care healthcare provider based in Kosciusko, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2018. The National Provider Identifier (NPI) number assigned to this provider is 1659871424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Hill, DNP, NP-C has received a total of $2,787 in payments from pharmaceutical and medical device companies, with $17.71 received in 2024. These payments were reported across 74 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,394).
As a Medicare-enrolled provider, Hill has provided services to 2,016 Medicare beneficiaries, totaling 2,462 services with total Medicare billing of $88,392. Data is available for 2 years (2020–2021), covering 29 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Other Specialties Adult Health, Women's Health
- Location Kosciusko, MS
- Active Since 02/17/2018
- Last Updated 01/14/2026
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1659871424
Products in Payments
- Axonics r-SNM System (Device) $1,717
- LO LOESTRIN FE (Drug) $303.35
- BOTOX (Biological) $178.45
- MYRBETRIQ (Drug) $85.12
- Dayvigo (Drug) $77.20
- CONTRAVE (Drug) $66.52
- ANNOVERA (Drug) $36.35
- TRINTELLIX (Drug) $34.72
- GEMTESA (Drug) $33.22
- APLENZIN (Drug) $22.00
- Restorelle (Device) $19.15
- XTANDI (Drug) $18.85
- BIJUVA (Drug) $18.53
- Myrbetriq (Drug) $16.56
- Uribel (Drug) $16.04
- PREMARIN (Drug) $15.52
- Infyna Chic (Device) $15.31
- UBRELVY (Drug) $13.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.